All Articles

Lotus Tech's new sustainability report isn't just about green goals; it's a strategic play for investor trust with zero recalls and ambitious carbon targets.

As new regulations unleash a flood of bond market data, MarketAxess's TraX Tape uses AI and a decade of refinement to turn chaos into actionable intelligence.

Memo Therapeutics' Potravitug shows promise in a Phase II trial, offering the first real weapon against a common virus that threatens kidney transplants.

Cross Timbers Royalty Trust's June distribution reveals a complex narrative of divergent commodity prices, falling volumes, and persistent operational costs.

A 'dream team' of pharma veterans has raised $180M to advance a next-gen oral drug, promising to transform the multi-billion dollar IBD market.

A massive conditional loan from the Pentagon's investment arm aims to transform a Utah uranium mill into a cornerstone of America's critical minerals strategy.

Hisense's VAR role at the World Cup is more than a tech deal. It's a high-stakes play to enhance game integrity, dominate a market, and redefine fan experience.

An investor tour reveals China's stunning sustainable tech, but the real challenge is financial. Can high-tech farms prove they are 'bankable'?

As Retevis offers military-tested two-way radios on Prime Day, businesses are discovering that true reliability doesn't come from a smartphone.

With enhanced GMP cell banking suites, Minaris integrates manufacturing and testing in Philadelphia, aiming to accelerate development in the booming CGT market.

As air disc brakes become the new standard, DRiV's Abex brand moves beyond parts to offer an integrated system, simplifying maintenance and boosting safety.

A new spray-dried plasma could end reliance on freezers, transforming trauma care from the battlefield to rural ERs. But can Velico navigate the path to market?

Asimov's AI-driven synthetic biology platform partners with McGill's Goodman Cancer Institute, aiming to break the manufacturing bottleneck for complex drugs.

A new patent gives CervoMed a long runway for its dementia drug, but can this IP victory secure the massive funding needed to cross the finish line?

Ambow Education launches HybriU ProjectHub, an AI platform aiming to unify a chaotic landscape of apps. But can it break through in a market dominated by titans?

Latin American software acquirer Nuvini is betting its future on 100% employee AI adoption, using an internal prize to transform its entire workforce.

As OMS Energy prepares its FY2026 results, its performance offers a unique window into the future of oil & gas in the pivotal Asia-MENA corridor.

Nephros is moving from a product company to a service-based model. We unpack the strategy, financial risks, and why this pivot could redefine its market.

Bitdeer reports a 370% surge in Bitcoin mining while aggressively converting its global power grid to support AI, deploying top-tier NVIDIA GPUs.

Dr. Glenn Parker's recent award is more than a trophy. It's a signal of a quiet revolution in healthcare—one that uses fintech to build national resilience.